Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis

International Journal of Cancer

Volumn 128, Issue 10, 2011, Pages 2326-2334

  Gannon, Philippe O ^a   Medelci, Sanae ^a   Le Page, Cécile ^a   Beaulieu, Martin ^b   Provencher, Diane M ^a,c,d   Mes Masson, Anne Marie ^a,d   Santos, Manuela M ^a,d,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e NONE   (Canada)

Author keywords

hemochromatosis; HFE mutations; iron; ovarian cancer; prognosis

Indexed keywords

HEMOCHROMATOSIS PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; EPITHELIAL OVARIAN CANCER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEMOCHROMATOSIS GENE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; ONCOGENE; OVARY CANCER; OVARY TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

EID: 79953201557     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25577     Document Type: Article

References (49)

1. Kwok JC, Richardson DR,. The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol 2002; 42: 65-78. (Pubitemid 34229148)
2. Winterbourn CC,. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett 1995; 82-83: 969-74. (Pubitemid 26054777)
3. Porto G, De Sousa M,. Iron overload and immunity. World J Gastroenterol 2007; 13: 4707-15. (Pubitemid 47455561)
4. Santos M, de Sousa M,. In vitro modulation of T-cell surface molecules by iron. Cell Immunol 1994; 154: 498-506. (Pubitemid 24115149)
5. Hentze MW, Muckenthaler MU, Andrews NC,. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004; 117: 285-97. (Pubitemid 38534536)
6. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408. (Pubitemid 26256612)
7. Nichols GM, Bacon BR,. Hereditary hemochromatosis: pathogenesis and clinical features of a common disease. Am J Gastroenterol 1989; 84: 851-62. (Pubitemid 19219756)
8. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC,. The hemochromatosis founder mutation in HLA-H disrupts b2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025-8. (Pubitemid 27232800)
9. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC,. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95: 1472-7. (Pubitemid 28103416)
10. Gross CN, Irrinki A, Feder JN, Enns CA,. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 1998; 273: 22068-74. (Pubitemid 28405389)
11. Salter-Cid L, Brunmark A, Li Y, Leturcq D, Peterson PA, Jackson MR, Yang Y,. Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis. Proc Natl Acad Sci USA 1999; 96: 5434-9. (Pubitemid 29234635)
12. Roy CN, Carlson EJ, Anderson EL, Basava A, Starnes SM, Feder JN, Enns CA,. Interactions of the ectodomain of HFE with the transferrin receptor are critical for iron homeostasis in cells. FEBS Lett 2000; 484: 271-4.
13. Roy CN, Penny DM, Feder JN, Enns CA,. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem 1999; 274: 9022-8. (Pubitemid 29164707)
14. Corsi B, Levi S, Cozzi A, Corti A, Altimare D, Albertini A, Arosio P,. Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype. FEBS Lett 1999; 460: 149-52. (Pubitemid 29479261)
15. Riedel HD, Muckenthaler MU, Gehrke SG, Mohr I, Brennan K, Herrmann T, Fitscher BA, Hentze MW, Stremmel W,. HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells. Blood 1999; 94: 3915-21.
16. Wang J, Chen G, Pantopoulos K,. The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin. Biochem J 2003; 370: 891-9. (Pubitemid 36399081)
17. Roy D, Cai Q, Felty Q, Narayan S,. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health Part B: Crit Rev 2007; 10: 235-57. (Pubitemid 47057178)
18. Kabat G, Rohan T,. Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis. Cancer Causes Control 2007; 18: 1047-53. (Pubitemid 47498168)
19. Beckman LE, Van Landeghem GF, Sikstrom C, Wahlin A, Markevarn B, Hallmans G, Lenner P, Athlin L, Stenling R, Beckman L,. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 1999; 20: 1231-3. (Pubitemid 29341443)
20. Kallianpur AR, Hall LD, Yadav M, Christman BW, Dittus RS, Haines JL, Parl FF, Summar ML,. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 205-12. (Pubitemid 38222550)
21. Osborne NJ, Gurrin LC, Allen KJ, Constantine CC, Delatycki MB, McLaren CE, Gertig DM, Anderson GJ, Southey MC, John KO, Powell LW, Hopper JL, et al. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology 2010; 51: 1311-8.
22. Kondrashova TV, Neriishi K, Ban S, Ivanova TI, Krikunova LI, Shentereva NI, Smirnova IA, Zharikova IA, Konova MV, Taira S, Tsyb AF,. Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers. Biochim Biophys Acta 2005; 1762: 59-65.
23. Gunel-Ozcan A, Alyilmaz-Bekmez S, Guler E, Guc D,. HFE H63D mutation frequency shows an increase in Turkish women with breast cancer. BMC Cancer 2006; 6: 37.
24. Abraham BK, Justenhoven C, Pesch B, Harth V, Weirich G, Baisch C, Rabstein S, Ko Y-D, Bruning T, Fischer H-P, Haas S, Brod S, et al. Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1102-7. (Pubitemid 40656454)
25. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG,. New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
26. Mangasser-Stephan K, Tag C, Reiser A, Gressner AM,. Rapid genotyping of hemochromatosis gene mutations on the lightcycler with fluorescent hybridization probes. Clin Chem 1999; 45: 1875-8. (Pubitemid 29477354)
27. Girouard J, Giguere Y, Delage R, Rousseau F,. Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients. Hum Mol Genet 2002; 11: 185-9. (Pubitemid 34157010)
28. Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 2008; 5: e232.
29. Nils M, Keld-Erik B, Lars O, Marianne K, Kirsten SLJ,. Iron status in Danish women, 1984-1994: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 2003; 71: 51-61.
30. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM,. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000; 140: 98-104. (Pubitemid 30471247)
31. Koziol JA, Ho NJ, Felitti VJ, Beutler E,. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 2001; 47: 1804-10. (Pubitemid 32881193)
32. Maccio A, Madeddu C, Massa D, Mudu MC, Lusso MR, Gramignano G, Serpe R, Melis GB, Mantovani G,. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood 2005; 106: 362-7. (Pubitemid 40967214)
33. Weiss G, Goodnough LT,. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
34. Beutler E, Waalen J,. Response to Moirand et al.-"HFE based re-evaluation of heterozygous hemochromatosis." Am J Med Genet 2004; 124A: 218-9. (Pubitemid 38036600)
35. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008; 358: 221-30.
36. Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, Delatycki MB, Southey MC, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, et al. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008; 135: 1945-52.
37. Fassl S, Leisser C, Huettenbrenner S, Maier S, Rosenberger G, Strasser S, Grusch M, Fuhrmann G, Leuhuber K, Polgar D, Stani J, Tichy B, et al. Transferrin ensures survival of ovarian carcinoma cells when apoptosis is induced by TNFalpha, FasL, TRAIL, or Myc. Oncogene 2003; 22: 8343-55. (Pubitemid 37485527)
38. Christopher RC, Srigiridhar K, Janine PW,. Expression of the hemochromatosis gene modulates the cytotoxicity of doxorubicin in breast cancer cells. Int J Cancer 2006; 119: 2200-4.
39. de Almeida SF, Carvalho IF, Cardoso CS, Cordeiro JV, Azevedo JE, Neefjes J, de Sousa M,. HFE cross-talks with the MHC class I antigen presentation pathway. Blood 2005; 106: 971-7. (Pubitemid 41076442)
40. Rohrlich PS, Fazilleau N, Ginhoux F, Firat H, Michel F, Cochet M, Laham N, Roth MP, Pascolo S, Nato F, Coppin H, Charneau P, et al. Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function. Proc Natl Acad Sci USA 2005; 102: 12855-60. (Pubitemid 41279455)
41. Porto G, Vicente C, Teixeira MA, Martins O, Cabeda JM, Lacerda R, Goncalves C, Fraga J, Macedo G, Silva BM, Alves H, Justica B, et al. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology 1997; 25: 397-402. (Pubitemid 27069061)
42. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G,. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-13. (Pubitemid 36077915)
43. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS,. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997; 94: 12384-9.
44. de Almeida SF, Fleming JV, Azevedo JE, Carmo-Fonseca M, de Sousa M,. Stimulation of an unfolded protein response impairs MHC class I expression. J Immunol 2007; 178: 3612-9. (Pubitemid 46417628)
45. Wang G, Yang ZQ, Zhang K,. Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res 2010; 2: 65-74.
46. Rutkowski DT, Kaufman RJ,. That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem Sci 2007; 32: 469-76. (Pubitemid 47588945)
47. Rabik CA, Fishel ML, Holleran JL, Kasza K, Kelley MR, Egorin MJ, Dolan ME,. Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress. J Pharmacol Exp Ther 2008; 327: 442-52.
48. Lawless MW, Mankan AK, White M, O'Dwyer MJ, Norris S,. Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol 2007; 8: 30.
49. Santos GC, Zielenska M, Prasad M, Squire JA,. Chromosome 6p amplification and cancer progression. J Clin Pathol 2007; 60: 1-7. (Pubitemid 46142665)